108 related articles for article (PubMed ID: 1981148)
1. Activation of tat-defective human immunodeficiency virus by ultraviolet light.
Sadaie MR; Tschachler E; Valerie K; Rosenberg M; Felber BK; Pavlakis GN; Klotman ME; Wong-Staal F
New Biol; 1990 May; 2(5):479-86. PubMed ID: 1981148
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E
Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403
[TBL] [Abstract][Full Text] [Related]
3. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
Popik W; Pitha PM
Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
[TBL] [Abstract][Full Text] [Related]
5. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
[TBL] [Abstract][Full Text] [Related]
6. Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication.
Verhoef K; Koper M; Berkhout B
Virology; 1997 Oct; 237(2):228-36. PubMed ID: 9356335
[TBL] [Abstract][Full Text] [Related]
7. Tat is required for efficient HIV-1 reverse transcription.
Harrich D; Ulich C; García-Martínez LF; Gaynor RB
EMBO J; 1997 Mar; 16(6):1224-35. PubMed ID: 9135139
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA.
Deng L; Wang D; de la Fuente C; Wang L; Li H; Lee CG; Donnelly R; Wade JD; Lambert P; Kashanchi F
Virology; 2001 Oct; 289(2):312-26. PubMed ID: 11689053
[TBL] [Abstract][Full Text] [Related]
9. GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system.
Chowdhury M; Kundu M; Khalili K
Oncogene; 1993 Apr; 8(4):887-92. PubMed ID: 8384357
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
11. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys.
Brother MB; Chang HK; Lisziewicz J; Su D; Murty LC; Ensoli B
Virology; 1996 Aug; 222(1):252-6. PubMed ID: 8806505
[TBL] [Abstract][Full Text] [Related]
12. Transduction of the human immunodeficiency virus type 1 promoter into human chromosomal DNA by adeno-associated virus: effects on promoter activity.
Nahreini P; Mathews MB
Virology; 1997 Jul; 234(1):42-50. PubMed ID: 9234945
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
14. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
Peng H; Callison D; Li P; Burrell C
Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
[TBL] [Abstract][Full Text] [Related]
15. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
Macías D; Oya R; Saniger L; Martín F; Luque F
Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
[TBL] [Abstract][Full Text] [Related]
16. Activation of HIV type 1 long terminal repeat by ultraviolet light is serum and strain specific.
Carrier F; McCary JM; Bae I; Yarosh DB; Fornace AJ
AIDS Res Hum Retroviruses; 1994 Jul; 10(7):767-73. PubMed ID: 7986581
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity.
Huang LM; Joshi A; Willey R; Orenstein J; Jeang KT
EMBO J; 1994 Jun; 13(12):2886-96. PubMed ID: 8026473
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of the tat-defective human immunodeficiency virus type-1 provirus: effect of interferon.
Popik W; Pitha PM
Virology; 1992 Aug; 189(2):435-47. PubMed ID: 1641975
[TBL] [Abstract][Full Text] [Related]
19. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline.
Kim BO; Liu Y; Ruan Y; Xu ZC; Schantz L; He JJ
Am J Pathol; 2003 May; 162(5):1693-707. PubMed ID: 12707054
[TBL] [Abstract][Full Text] [Related]
20. The presence of tat protein or tumor necrosis factor alpha is critical for herpes simplex virus type 1-induced expression of human immunodeficiency virus type 1.
Popik W; Pitha PM
J Virol; 1994 Mar; 68(3):1324-33. PubMed ID: 8107197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
